Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, AnaptysBio Inc’s stock clocked out at $20.4, up 2.20% from its previous closing price of $19.96. In other words, the price has increased by $2.20 from its previous closing price. On the day, 0.45 million shares were traded. ANAB stock price reached its highest trading level at $20.43 during the session, while it also had its lowest trading level at $19.7101.
Ratios:
To gain a deeper understanding of ANAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.22 and its Current Ratio is at 8.22.
H.C. Wainwright Downgraded its Buy to Neutral on December 11, 2024, whereas the target price for the stock was revised from $52 to $19.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 08 ’25 when RENTON HOLLINGS sold 10,231 shares for $19.62 per share. The transaction valued at 200,714 led to the insider holds 4,965 shares of the business.
HOLLINGS C RENTON bought 10,231 shares of ANAB for $200,713 on Aug 08 ’25. On Jul 02 ’25, another insider, RENTON HOLLINGS, who serves as the Director of the company, sold 20,925 shares for $23.57 each. As a result, the insider received 493,191 and left with 4,965 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 570649216 and an Enterprise Value of 651885056. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.64. Its current Enterprise Value per Revenue stands at 5.293 whereas that against EBITDA is -7.619.
Stock Price History:
The Beta on a monthly basis for ANAB is -0.19, which has changed by -0.44292736 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, ANAB has reached a high of $40.70, while it has fallen to a 52-week low of $12.21. The 50-Day Moving Average of the stock is -12.89%, while the 200-Day Moving Average is calculated to be 2.51%.
Shares Statistics:
It appears that ANAB traded 576.66K shares on average per day over the past three months and 386710 shares per day over the past ten days. A total of 27.97M shares are outstanding, with a floating share count of 25.59M. Insiders hold about 8.58% of the company’s shares, while institutions hold 119.88% stake in the company. Shares short for ANAB as of 1755216000 were 9595647 with a Short Ratio of 16.64, compared to 1752537600 on 9380774. Therefore, it implies a Short% of Shares Outstanding of 9595647 and a Short% of Float of 64.519995.
Earnings Estimates
The dynamic stock of AnaptysBio Inc (ANAB) is currently being evaluated by a team of 8.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.76, with high estimates of $1.18 and low estimates of -$1.91.
Analysts are recommending an EPS of between -$2.03 and -$6.23 for the fiscal current year, implying an average EPS of -$4.8. EPS for the following year is -$5.29, with 8.0 analysts recommending between -$2.7 and -$8.15.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for ANAB’s current fiscal year. The highest revenue estimate was $225.8M, while the lowest revenue estimate was $50.03M, resulting in an average revenue estimate of $111.15M. In the same quarter a year ago, actual revenue was $91.28M
